Canopy Growth Cannabis Cultivation Platform of 5.6 Million Square Feet Now 75% Licensed

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

 

Canopy Growth Increases Licensed Platform – 4.3 Million Square Feet Now Licensed Across Canada

SMITHS FALLS, ON, Oct. 9, 2018 /CNW/ – Licence amendments for Canopy Growth Corporation‘s (“Canopy Growth” or the “Company”) wholly-owned subsidiary, BC Tweed Joint Venture Inc. (BC Tweed) and its majority-owned joint venture, Les Serres Vert Cannabis Inc. (Vert Cannabis) have been issued by Health Canada, collectively representing approximately 1.1 million sq. ft. of new greenhouse growing space on Canada’s largest cannabis platform.

The Company has, through its subsidiaries, established a 5.6 million sq. ft. platform, which is now over 75% licensed. This infrastructure will increase the quantity and diversity of products available to retail and wholesale customers in the recreational market and fortify the supply of cannabis products available to its medical customers.

Our regulatory team and the teams in Delta and Mirabel have worked hard to bring these large-scale greenhouses online. Credit is due to these teams and the entire organization as we continue the push forward into a transformative year for our business.

Mark Zekulin, President and co-CEO, Canopy Growth

These licence amendments are a major step forward but more capacity is required before the entire Canopy Growth platform is operational.

Here’s to Future Growth (all across the country).

About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

The Company has operations in 11 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.3 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. For more information visit www.canopygrowth.com

Original press release

The most reliable, fact-based information on Canopy Growth Corp. found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter